Atlas Trials

Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke

Clinical trial NCT05363397 · RECRUITING

Trial details

NCT number
NCT05363397
Sponsor
The Florey Institute of Neuroscience and Mental Health
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Ischemic Stroke
Start date
2023-09-27
Primary completion
2026-02-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.